{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:01:00Z","timestamp":1791946860298,"version":"4.3.4"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201884","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T13:30:02Z","timestamp":1533907802000},"page":"e0201884","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarction"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9587-7929","authenticated-orcid":true,"given":"Mich\u00e8le","family":"Bally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0466-0260","authenticated-orcid":true,"given":"Lyne","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"TE McAlindon","year":"2014","journal-title":"Osteoarthritis and cartilage \/ OARS, Osteoarthritis Research Society"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12916-015-0285-8","article-title":"Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis\u2014an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks","volume":"13","author":"C Scarpignato","year":"2015","journal-title":"BMC medicine"},{"issue":"26","key":"ref3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"SE Nissen","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.clinthera.2011.10.019","article-title":"Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis","volume":"33","author":"M Gore","year":"2011","journal-title":"Clin Ther"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.653","article-title":"Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom","volume":"10","author":"M Langman","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref6","unstructured":"GetReal. New methods for RWE collection and synthesis. WP1: D1.3 GetReal Glossary\u2014Including Comments &amp; Replies from Consultation Rounds. Retrieved from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.imi-getreal.eu\/Publications\/Deliverables-and-reports\" xlink:type=\"simple\">https:\/\/www.imi-getreal.eu\/Publications\/Deliverables-and-reports<\/ext-link>. Last accessed on October 13, 2017."},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/EDE.0b013e318193e7b5","article-title":"Interactions in epidemiology: relevance, identification, and estimation","volume":"20","author":"S Greenland","year":"2009","journal-title":"Epidemiology"},{"key":"ref8","first-page":"71","article-title":"Modern Epidemiology","author":"S Greenland","year":"2008"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/oxfordjournals.aje.a113015","article-title":"Concepts of interaction","volume":"112","author":"KJ Rothman","year":"1980","journal-title":"Am J Epidemiol"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","article-title":"The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec","volume":"48","author":"R Tamblyn","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0895-4356(03)00246-4","article-title":"Validation of diagnostic codes within medical services claims","volume":"57","author":"M Wilchesky","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cjca.2011.10.005","article-title":"Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data?","volume":"28","author":"L Lambert","year":"2012","journal-title":"Can J Cardiol"},{"issue":"11","key":"ref13","first-page":"1277","article-title":"Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction","volume":"15","author":"AR Levy","year":"1999","journal-title":"Can J Cardiol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.4358","article-title":"Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure","volume":"27","author":"M Bally","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data","volume":"357","author":"M Bally","year":"2017","journal-title":"BMJ"},{"issue":"9651","key":"ref16","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(08)61490-7","article-title":"Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial","volume":"372","author":"JA Baron","year":"2008","journal-title":"Lancet"},{"issue":"21","key":"ref17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"C Bombardier","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"RS Bresalier","year":"2005","journal-title":"N Engl J Med"},{"issue":"21","key":"ref19","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/archinternmed.2009.394","article-title":"Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance","volume":"169","author":"JS Ross","year":"2009","journal-title":"Arch Intern Med"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/STROKEAHA.110.585828","article-title":"Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: A nationwide case-crossover study","volume":"41","author":"CH Chang","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Y Kiyota","year":"2004","journal-title":"American heart journal"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/pds.1924","article-title":"Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population","volume":"19","author":"PM Wahl","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2013.08.005","article-title":"Mechanisms of aspirin resistance","volume":"141","author":"CN Floyd","year":"2014","journal-title":"Pharmacology & therapeutics"},{"issue":"25","key":"ref24","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2010.04.003","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes","volume":"55","author":"M Pignone","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.ajkd.2008.11.034","article-title":"Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis","volume":"53","author":"SG Coca","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref26","article-title":"Association between osteoarthritis and cardiovascular disease: systematic review and meta-analysis","author":"AJ Hall","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"25","key":"ref27","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/CIRCULATIONAHA.106.685206","article-title":"Pulmonary diseases and the heart","volume":"116","author":"MK Han","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehi880","article-title":"Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population","volume":"27","author":"C Meisinger","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research","volume":"10","author":"S Greenland","year":"1999","journal-title":"Epidemiology"},{"key":"ref30","article-title":"A review of covariate selection for non-experimental comparative effectiveness research","author":"BC Sauer","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"JM Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2036.2006.02985.x","article-title":"Validation of administrative data used for the diagnosis of upper gastrointestinal events following nonsteroidal anti-inflammatory drug prescription","volume":"24","author":"NS Abraham","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref33","unstructured":"American Health Information Management Association. Coding for peripheral vascular disease (PVD). Audio seminar\/webinar. August 20, 2009. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/campus.ahima.org\/audio\/2009\/RB082009.pdf\" xlink:type=\"simple\">http:\/\/campus.ahima.org\/audio\/2009\/RB082009.pdf<\/ext-link>. Last accessed on October 13, 2017."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pds.2312","article-title":"A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data","volume":"21","author":"SE Andrade","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1472-6963-11-37","article-title":"The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease","volume":"11","author":"CR Cooke","year":"2011","journal-title":"BMC health services research"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pds.1518","article-title":"Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data","volume":"17","author":"CL Roumie","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pds.2313","article-title":"A systematic review of validated methods for identifying heart failure using administrative data","volume":"21","author":"JS Saczynski","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0828-282X(06)70237-9","article-title":"Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management","volume":"22","author":"JM Arnold","year":"2006","journal-title":"Can J Cardiol"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjmed.2003.11.025","article-title":"Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000","volume":"116","author":"DS Lee","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"ref40","first-page":"347","article-title":"The 2002\/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure","volume":"19","author":"P Liu","year":"2003","journal-title":"Can J Cardiol"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.110249","article-title":"Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort","volume":"38","author":"R Tavares","year":"2011","journal-title":"The Journal of rheumatology"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interactions","volume":"3","author":"TJ VanderWeele","year":"2014","journal-title":"Epidemiol Method"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-5-5","article-title":"Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure","volume":"5","author":"V Essebag","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"H Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/jgs.12156","article-title":"Apolipoprotein E epsilon4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults","volume":"61","author":"MA Beydoun","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"key":"ref46","first-page":"310","article-title":"Modern Epidemiologic Approaches to Interaction: Applications to the Study of Genetic Interactions","author":"S Schwartz","year":"2006","journal-title":"Genes, Behavior, and the Social Environment: Moving Beyond the Nature\/Nurture Debate Committee on Assessing Interactions Among Social, Behavioral, and Genetic Factors in Health"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/aje\/kwr009","article-title":"Remarks on antagonism","volume":"173","author":"TJ VanderWeele","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2007.11.054","article-title":"The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers","volume":"101","author":"PA Gladding","year":"2008","journal-title":"Am J Cardiol"},{"issue":"47","key":"ref49","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.1073\/pnas.1406997111","article-title":"Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs","volume":"111","author":"X Li","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clpt.2006.05.004","article-title":"Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease","volume":"80","author":"G Renda","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref51","article-title":"Supplement to: Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","author":"SE Nissen","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","article-title":"The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs","volume":"38","author":"T Grosser","year":"2017","journal-title":"Trends in pharmacological sciences"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cpt.696","article-title":"Coxibs, traditional NSAIDs, and cardiovascular safety post-PRECISION: what we tought we knew then and what we think we know now","volume":"102","author":"C Patrono","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","article-title":"Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs","volume":"108","author":"T Kurth","year":"2003","journal-title":"Circulation"},{"issue":"25","key":"ref55","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"F Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00228-012-1370-y","article-title":"Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study","volume":"69","author":"IL Meek","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1476-5381.2009.00243.x","article-title":"The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers","volume":"157","author":"MP Schuijt","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"ref58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2013.09.032","article-title":"Drug\/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets","volume":"721","author":"A Saxena","year":"2013","journal-title":"European journal of pharmacology"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejps.2008.10.015","article-title":"Kinetic modelling of NSAID action on COX-1: focus on in vitro\/in vivo aspects and drug combinations","volume":"36","author":"A Goltsov","year":"2009","journal-title":"European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","article-title":"Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1","volume":"107","author":"G Rimon","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cpt.21","article-title":"Inhibition of antiplatelet effects of aspirin by nonopioid analgesics","volume":"97","author":"T Hohlfeld","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/17425255.2014.971010","article-title":"Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs&apos; antiplatelet effects","volume":"11","author":"D Stepensky","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjmed.2013.08.017","article-title":"NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease","volume":"127","author":"P Kohli","year":"2014","journal-title":"Am J Med"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/hrt.2006.089367","article-title":"The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction","volume":"93","author":"JM Brophy","year":"2007","journal-title":"Heart"},{"issue":"4","key":"ref65","article-title":"Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan&apos;s National Health Insurance claims database and review of current evidence","volume":"12","author":"WY Shau","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"issue":"20","key":"ref66","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","article-title":"Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population","volume":"52","author":"LA Garcia Rodriguez","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"ref67","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.23911","article-title":"Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups","volume":"59","author":"DH Solomon","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.22614","article-title":"Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective cyclooxygenase 2 inhibitors: a class effect?","volume":"57","author":"M Hudson","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"ref69","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/EDE.0000000000000121","article-title":"A unification of mediation and interaction: a 4-way decomposition","volume":"25","author":"TJ VanderWeele","year":"2014","journal-title":"Epidemiology"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/HJH.0b013e3283310dc9","article-title":"Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis","volume":"27","author":"CC Chan","year":"2009","journal-title":"J Hypertens"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"AG Johnson","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"JE Pope","year":"1993","journal-title":"Arch Intern Med"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/08037051.2017.1290503","article-title":"Non-steroidal anti-inflammatory drugs and blood pressure control in patients treated for hypertension: results from the Swedish primary care cardiovascular database","volume":"26","author":"C Ljungman","year":"2017","journal-title":"Blood pressure"},{"key":"ref74","first-page":"320","author":"TJ VanderWeele","year":"2015"},{"issue":"22","key":"ref75","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/sim.4354","article-title":"Sensitivity analysis for interactions under unmeasured confounding","volume":"31","author":"TJ VanderWeele","year":"2012","journal-title":"Stat Med"},{"key":"ref76","first-page":"249","article-title":"Explanation in Causal Inference. Methods for Mediation and Interaction","author":"TJ VanderWeele","year":"2015"},{"issue":"Suppl 4","key":"ref77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1289\/ehp.93101s459","article-title":"Basic problems in interaction assessment","volume":"101","author":"S Greenland","year":"1993","journal-title":"Environmental health perspectives"},{"issue":"7","key":"ref78","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jclinepi.2014.02.008","article-title":"Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: results from a systematic review and simulation study","volume":"67","author":"AF Schmidt","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/EDE.0b013e318208750e","article-title":"Estimating the relative excess risk due to interaction: a Bayesian approach","volume":"22","author":"H Chu","year":"2011","journal-title":"Epidemiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:24:27Z","timestamp":1540200267000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201884"}},"subtitle":[],"editor":[{"given":"Christine","family":"Leong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201884","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]}}}